Most decongestants cause response from adrenoreceptor a1, chiefly responsible for vasoconstriction (a2 modulates adrenaline/noradrenaline levels, b1 is the most stimulating and increases cardiac output, b2 dilates the bronchial walls, and b3 induces lipolysis). The effects are not limited to the nose and these medicines can increase hypertension (blood pressure) through vasoconstriction, but most decongestants are not pronounced stimulants due to lack of response from the other adrenoreceptors.
These are normally paired with antihistamines to lessen this effect, but they don't always even each other out.
The most common oral decongestants are pseudoephedrine and phenylephrine; phenylpropanolamine (PPA) is another, although it's no longer available in the US. Oxymetazoline and phenylephrine are a commonly available topical decongestants (nasal sprays).
- Nasal congestion (includes non-pharmacological remedies)
- Topical decongestant
Decongestants and other nasal preparations (R01)
|Topical: sympathomimetics, plain||Cyclopentamine - Ephedrine - Phenylephrine - Oxymetazoline - Tetryzoline - Xylometazoline - Naphazoline - Tramazoline - Metizoline - Tuaminoheptane - Fenoxazoline - Tymazoline - Epinephrine|
|Topical: antiallergic agents, excluding corticosteroids||Cromoglicic acid - Levocabastine - Azelastine - Antazoline - Spaglumic acid - Thonzylamine - Nedocromil - Olopatadine|
|Topical: corticosteroids||Beclometasone - Prednisolone - Dexamethasone - Flunisolide - Budesonide - Betamethasone - Tixocortol - Fluticasone - Mometasone furoate - Triamcinolone - Ciclesonide|
|Topical: other nasal preparations||Calcium hexamine thiocyanate - Retinol - Ipratropium bromide - Ritiometan - Mupirocin - Hexamidine - Framycetin|
|Systemic use: Sympathomimetics||Phenylpropanolamine - Pseudoephedrine - Phenylephrine|
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies